Moneycontrol PRO
HomeNewsIndiaCOVID-19 vaccine tracker: Over 54 lakh jabs administered on August 20; total coverage crosses 57 crore

COVID-19 vaccine tracker: Over 54 lakh jabs administered on August 20; total coverage crosses 57 crore

On the 216th day of the vaccination drive on August 19, 54,71,282 beneficiaries received the jab, pushing India's total coverage to 57,22,81,488.

August 20, 2021 / 11:53 IST
(Image Source: Reuters/Jose Cabezas)

More than 54 lakh COVID-19 vaccine doses were administered in India on August 19, the Union Health Ministry's latest report suggested. With that, the cumulative number of COVID-19 vaccine doses administered in the country crossed 57 crore.

On the 216th day of the vaccination drive on August 19, 54,71,282 beneficiaries received the jab, pushing India's total coverage to 57,22,81,488.

Here are key developments related to the COVID-19 vaccination process:

- Union Health Minister Mansukh Mandaviya said results of an ongoing research for development of COVID-19 vaccines for children may arrive next month and the antidote may be launched "very soon". "Our aim is to vaccinate every citizen. The Indian government has already given permission to Zydus Cadila and Bharat Biotech to conduct research for developing a COVID-19 vaccine for children.

- The Telangana government is working towards making Hyderabad a "100 percent COVID-19 vaccinated city" in the next 15 days. State Chief Secretary Somesh Kumar, who addressed a workshop on Thursday, said the officials of health department and Greater Hyderabad Muncipal Corporation (GHMC), besides field staff should work in close coordination to make all the residential colonies in the city 100 per cent vaccinated, an official release said.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

- The total number of COVID-19 vaccine doses administered in the country has crossed 57.16 crore, including over 48 lakh doses given on Thursday, according to the Union health ministry. While 26,66,831 beneficiaries in the age group of 18-44 years received the first dose, 6,01,437 were administered the second dose of the vaccine on Thursday, the ministry said in a statement.

- The COVID-19 vaccination drive will remain suspended at the civic and state government-run centers in Mumbai on August 19 and 20 due to a shortage of vaccine doses, the Brihanmumbai Municipal Corporation (BMC) said on Wednesday. This is for the third consecutive week in August that the civic authority has suspended the drive due to a shortage of vaccine doses.

- The national capital's stock of anti-coronavirus vaccine will only last for three days, according to a vaccination bulletin issued by the Delhi government on Thursday. As of Thursday morning, the balance stock of the vaccines -- Covaxin and Covishield -- was 2,36,330 and 3,05,990 doses, respectively, it said.

- Over 3.86 crore people did not get their second dose of anti-Covid vaccines -- Covishield and Covaxin -- within the stipulated period of time, the government has said in response to an RTI query. According to information on the CoWIN portal, as of Thursday afternoon 44,22,85,854 people have received their first dose, while 12,59,07,443 have also taken their second.

Click here for Moneycontrol’s full coverage of the coronavirus pandemic

Moneycontrol News
first published: Aug 20, 2021 11:53 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
CloseOutskill Genai